Arun Singh

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Platelet Rich Plasma

Cross Sectional

Bipolar Disorder

Physical Activity

Top Venues

Neuropsychiatric disease and treatment

Patient preference and adherence

This page only lists publications with an associated author ORCID identifier.

Publications

Cesar Giron-Hernandez, Joong Hee Han, Roberta Alberio, Arun Singh, Maria Paz García-Portilla, Maurizio Pompili, R Karl Knight, Ute Richarz, Srihari Gopal, José Antunes
Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study. Neuropsychiatric disease and treatment 19 (2023)
Erica A Voss, Saberi Rana Ali, Arun Singh, Peter R Rijnbeek, Martijn J Schuemie, Daniel Fife
Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study. Drug safety 45 (7) (2022)
Gang Li, Alexander Keenan, Mehmet Daskiran, Maju Mathews, Isaac Nuamah, Camille Orman, Kruti Joshi, Arun Singh, Annabelle Godet, Katalin Pungor, Srihari Gopal
Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis. Patient preference and adherence 15 (2021)
Maju Mathews, Srihari Gopal, Arun Singh, Isaac Nuamah, Katalin Pungor, Wilson Tan, Bernardo Soares, Edward Kim, Adam J Savitz
Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies. Neuropsychiatric disease and treatment 16 (2020)
Clifton Blackwood, Panna Sanga, Isaac Nuamah, Alexander Keenan, Arun Singh, Maju Mathews, Srihari Gopal
Patients' Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire. Patient preference and adherence 14 (2020)
Srihari Gopal, Jagadish Gogate, Katalin Pungor, Edward Kim, Arun Singh, Maju Mathews
Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study. Neuropsychiatric disease and treatment 16 (2020)